376 related articles for article (PubMed ID: 27485484)
1. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
[TBL] [Abstract][Full Text] [Related]
2. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
3. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
[TBL] [Abstract][Full Text] [Related]
4. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
5. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na
de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R
Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804
[TBL] [Abstract][Full Text] [Related]
6. Identification of an I
Ma D; Liu Z; Loh LJ; Zhao Y; Li G; Liew R; Islam O; Wu J; Chung YY; Teo WS; Ching CK; Tan BY; Chong D; Ho KL; Lim P; Yong RYY; Panama BK; Kaplan AD; Bett GCL; Ware J; Bezzina CR; Verkerk AO; Cook SA; Rasmusson RL; Wei H
Sci Rep; 2018 Jul; 8(1):11246. PubMed ID: 30050137
[TBL] [Abstract][Full Text] [Related]
7. Ajmaline blocks I
Miller DC; Harmer SC; Poliandri A; Nobles M; Edwards EC; Ware JS; Sharp TV; McKay TR; Dunkel L; Lambiase PD; Tinker A
Stem Cell Res; 2017 Dec; 25():233-244. PubMed ID: 29172153
[TBL] [Abstract][Full Text] [Related]
8. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
[TBL] [Abstract][Full Text] [Related]
9. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.
Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR
Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
[TBL] [Abstract][Full Text] [Related]
11. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
[TBL] [Abstract][Full Text] [Related]
12. Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes.
Li Y; Dinkel H; Pakalniskyte D; Busley AV; Cyganek L; Zhong R; Zhang F; Xu Q; Maywald L; Aweimer A; Huang M; Liao Z; Meng Z; Yan C; Prädel T; Rose L; Moscu-Gregor A; Hohn A; Yang Z; Qiao L; Mügge A; Zhou X; Akin I; El-Battrawy I
Clin Transl Med; 2023 Mar; 13(3):e1130. PubMed ID: 36881552
[TBL] [Abstract][Full Text] [Related]
13. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
[TBL] [Abstract][Full Text] [Related]
14. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
15. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Zhong R; Schimanski T; Zhang F; Lan H; Hohn A; Xu Q; Huang M; Liao Z; Qiao L; Yang Z; Li Y; Zhao Z; Li X; Rose L; Albers S; Maywald L; Müller J; Dinkel H; Saguner A; Janssen JWG; Swamy N; Xi Y; Lang S; Kleinsorge M; Duru F; Zhou X; Diecke S; Cyganek L; Akin I; El-Battrawy I
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955449
[TBL] [Abstract][Full Text] [Related]
16. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
[TBL] [Abstract][Full Text] [Related]
18. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.
Selga E; Sendfeld F; Martinez-Moreno R; Medine CN; Tura-Ceide O; Wilmut SI; Pérez GJ; Scornik FS; Brugada R; Mills NL
J Mol Cell Cardiol; 2018 Jan; 114():10-19. PubMed ID: 29024690
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome.
Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P
Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791
[TBL] [Abstract][Full Text] [Related]
20. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
